Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Results

12 May 2011 12:28

RNS Number : 4915G
Skyepharma PLC
12 May 2011
 



SKYEPHARMA PLC - RESULT OF AGM

 

LONDON, UK, 12 May 2011 - SkyePharma PLC (LSE: SKP) announces the results of the voting by shareholders at the Annual General Meeting held earlier today. All resolutions were passed with the requisite majorities on a show of hands.

 

In accordance with Listing Rule 9.6.2, a copy of the resolutions passed, other than resolutions concerning ordinary business, will shortly be submitted to the National Storage Mechanism, and will be available for inspection at www.hemscott.com/nsm.do.

 

The full text of all the resolutions passed at the meeting can be found in the Notice of Annual General Meeting, which is available for inspection at www.hemscott.com/nsm.do and on the Company's website at www.skyepharma.com.

 

Full details of the proxy voting will be available on our website (www.skyepharma.com) later today.

 

For further information please contact:

 

SkyePharma PLC

Peter Grant

+44 20 7881 0524

John Murphy

Financial Dynamics

Jonathan Birt

+44 20 7831 3113

Susan Quigley

 

About SkyePharma PLC

Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage. The Group has twelve approved products in the areas of oral, inhalation and topical delivery. The Group's products are marketed throughout the world by leading pharmaceutical companies. For more information, visit www.skyepharma.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFLLFFFEFLBBQ
Date   Source Headline
8th May 20067:02 amRNSConference Call Details
8th May 20067:01 amRNSFlutiform Deal
3rd May 20069:57 amRNSShare Purchase Plan
2nd May 200611:23 amRNSNotification of Shares
28th Apr 20067:02 amRNSEuropean Approval of Depodur
26th Apr 20062:32 pmRNSNotification of Interests
24th Apr 20064:23 pmRNSDirectors Share Awards
24th Apr 20062:29 pmRNSNotification of Interests
24th Apr 20061:38 pmRNSHolding(s) in Company
21st Apr 200611:16 amRNSPropofol Update
19th Apr 20067:02 amRNSPreliminary Results
5th Apr 20062:00 pmRNSBoard Appointment
3rd Apr 20065:43 pmRNSShare Purchase Plan
27th Mar 20069:06 amRNSNotice of Results
17th Mar 200610:15 amRNSNotification of Shares
15th Mar 20062:57 pmRNSNotification of Shares
14th Mar 20067:03 amRNSAgreement over Non-Executives
9th Mar 20063:46 pmRNSResult of EGM
6th Mar 20061:10 pmRNSHolding(s) in Company
3rd Mar 20065:06 pmRNSFinancial Position
3rd Mar 20064:12 pmRNSNotification of Shares
3rd Mar 200610:59 amRNSRule 8.3- Skyepharma PLC
2nd Mar 20064:58 pmRNSResponse to NAV
2nd Mar 20069:59 amRNSResponse to NAV
2nd Mar 20067:40 amRNSEGM Statement
1st Mar 20064:43 pmRNSShare Purchase Plan
27th Feb 20069:37 amRNSEGM Nominee Voting
23rd Feb 20062:14 pmRNSNotification of Shares
23rd Feb 200612:13 pmRNSNotification of Shares
16th Feb 20067:02 amRNSEGM Circular
15th Feb 20063:33 pmRNSDirector/PDMR Shareholding
14th Feb 20065:23 pmRNSNotification of Shares
13th Feb 20065:24 pmRNSNotification of Shares
13th Feb 200610:36 amRNSNotification of Shares
13th Feb 20067:01 amRNSFormer Chairman Retires
9th Feb 20062:34 pmRNSNotification of Shares
9th Feb 200612:35 pmRNSNotification of Shares
9th Feb 20067:01 amRNSFurther Re Employment Terms
8th Feb 20063:33 pmRNSNotification of Shares
7th Feb 20064:29 pmRNSNotification of Shares
7th Feb 20063:30 pmRNSResponse to NAV Syndicate
6th Feb 20063:26 pmRNSNotification of Shares
6th Feb 20063:23 pmRNSNotification of Shares
6th Feb 20067:01 amRNSBoard Appointment
3rd Feb 20063:22 pmRNSNotification of Shares
3rd Feb 200611:19 amRNSDirector Shareholding
3rd Feb 200611:12 amRNSDirector/PDMR Shareholding
3rd Feb 200610:37 amRNSDirector/PDMR Shareholding
2nd Feb 20063:20 pmRNSRule 8.3- (Skyepharma Group)
2nd Feb 200612:08 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.